Century Therapeutics, Inc Email Format

Biotechnology ResearchPennsylvania, United States51-200 Employees

Century Therapeutics, Inc. is a biotechnology research company headquartered in Philadelphia, Pennsylvania, with a workforce of 51 to 200 employees. The company is developing an allogeneic, iPSC-derived cell therapy platform for autoimmune diseases and cancer, integrating gene editing, protein engineering, and scalable development and manufacturing capabilities. It operates as a publicly traded entity on the NASDAQ under the ticker IPSC, having gone public in 2021. Public data indicate the company has reported revenue in the low-to-mid single digits and has raised approximately $60 million in funding. Century Therapeutics engages with the scientific and investor communities through conference appearances and presentations, including events such as the ADA Scientific Sessions.

Sign up for free to view info

Company overview Employee directory